References
Sbardella E, Isidori AM, Arnaldi G et al (2018) Approach to hyponatremia according to the clinical setting: consensus statement from the Italian society of endocrinology (SIE), Italian society of nephrology (SIN), and Italian association of medical oncology (AIOM). J Endocrinol Invest 41:3–19. https://doi.org/10.1007/s40618-017-0776-x
Spasovski G, Vanholder R, Allolio B et al (2014) Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol 170:G1-47. https://doi.org/10.1530/EJE-13-1020
Verbalis JG, Goldsmith SR, Greenberg A et al (2013) Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med 126:S1–S42. https://doi.org/10.1016/j.amjmed.2013.07.006
Corona G, Giuliani C, Parenti G et al (2013) Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis. PLoS ONE 8:e80451. https://doi.org/10.1371/journal.pone.0080451
Corona G, Norello D, Parenti G et al (2018) Hyponatremia, falls and bone fractures: a systematic review and meta-analysis. Clin Endocrinol (Oxf) 89:505–513. https://doi.org/10.1111/cen.13790
Suárez V, Norello D, Sen E et al (2020) Impairment of neurocognitive functioning, motor performance, and mood stability in hospitalized patients with euvolemic moderate and profound hyponatremia. Am J Med 133:986-993.e5. https://doi.org/10.1016/j.amjmed.2019.12.056
Ahluwalia V, Wade JB, Thacker L et al (2013) Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis. J Hepatol 59:467–473. https://doi.org/10.1016/j.jhep.2013.04.023
Corona G, Giukiani C, Parenti G et al (2016) The economic burden of hyponatremia: systematic review and meta-analysis. Am J Med 129:823-835.e4. https://doi.org/10.1016/j.amjmed.2016.03.007
Greenberg A, Verbalis JG, Amin AN et al (2015) Current treatment practice and outcomes. Report of the hyponatremia registry. Kidney Int 88:167–177. https://doi.org/10.1038/ki.2015.4
Tzoulis P, Waung JA, Bagkeris E et al (2016) Real-life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion. Clin Endocrinol 84:620–626. https://doi.org/10.1111/cen.12943
Mohmand HK, Issa D, Ahmad Z et al (2007) Hypertonic saline for hyponatremia: risk of inadvertent overcorrection. Clin J Am Soc Nephrol 2:1110–1117. https://doi.org/10.2215/CJN.00910207
Garrahy A, Dineen R, Hannon AM et al (2019) Continuous versus bolus infusion of hypertonic saline in the treatment of symptomatic hyponatremia caused by SIAD. J Clin Endocrinol Metab 104:3595–3602. https://doi.org/10.1210/jc.2019-00044
Rondon-Berrios H, Tandukar S, Mor MK et al (2018) Urea for the treatment of hyponatremia. Clin J Am Soc Nephrol 13:1627–1632. https://doi.org/10.2215/CJN.04020318
Decaux G, Gankam Kengne F, Couturier B et al (2014) Actual therapeutic indication of an old drug: urea for treatment of severely symptomatic and mild chronic hyponatremia related to SIADH. J Clin Med 3:1043–1049. https://doi.org/10.3390/jcm3031043
Nervo A, D’Angelo V, Rosso D et al (2019) Urea in cancer patients with chronic SIAD-induced hyponatremia: old drug, new evidence. Clin Endocrinol (Oxf) 90:842–848. https://doi.org/10.1111/cen.13966
Phillips GB, Schwartz R, Gabuzda GJ, Davidson CS (1952) The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances. N Engl J Med 247:239–246. https://doi.org/10.1056/NEJM195208142470703
Bioletto F, Varaldo E, Prencipe N et al (2023) Long-term efficacy of empagliflozin as an add-on treatment for chronic SIAD: a case report and literature review. Hormones (Athens). https://doi.org/10.1007/s42000-023-00430-0
Perelló-Camacho E, Pomares-Gómez FJ, López-Penabad L et al (2022) Clinical efficacy of urea treatment in syndrome of inappropriate antidiuretic hormone secretion. Sci Rep 12:10266. https://doi.org/10.1038/s41598-022-14387-4
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors received a travel grant from Cantabria Labs Difa Cooper.
Research involving human participants and/or animals
Not applicable.
Informed consent
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Arnaldi, G., Arvat, E., Berton, A.M. et al. Endocrinologists at work: management of hyponatremia in clinical practice. J Endocrinol Invest 46, 2453–2457 (2023). https://doi.org/10.1007/s40618-023-02147-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-023-02147-8